Reducing Allergic Manifestations in Children with Cow’s Milk Allergy: Current Research
Roberto Berni Canani, MD, PhD
, chief of the Pediatric Allergy Program in the Department of Translational Medicine, University of Naples, Italy, presents data from a trial of infants with cow’s milk allergy (CMA). In Dr. Canani’s trial, allergic manifestations during a 36-month trial of extensively hydrolyzed formula, with or without Lactobacillus rhamnosus
GG, were determined in infants who had developed CMA between 1-12 months of age. Dr. Canani’s research has implications for the treatment of cow’s milk intolerance, and long-term outcomes for children who develop CMA, since substitutive formulas can be used to treat these patients.
To proceed with this Activity, please